[artículo] 
inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65

Título :	Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group
Tipo de documento:	texto impreso
Autores:	Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 59-65
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol.
Resumen:	Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established.
Link:	./index.php?lvl=notice_display&id=31138

[artículo] Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group [texto impreso] / Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor . - 2023 . - pp. 59-65.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65

Palabras clave:	Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol.
Resumen:	Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established.
Link:	./index.php?lvl=notice_display&id=31138